Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis

Background: Trastuzumab is associated with the risk of cardiotoxicity. Here, we aim to explore interventions for preventing trastuzumab-related cardiotoxic effects in breast cancer patients. Methods: A systematic review was performed including trials of breast cancer patients with intervention to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinyi, Wu, Ziyang, Du, Xin, Wu, Yibo, Xie, Xiaohui, Shi, Luwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416464/
https://www.ncbi.nlm.nih.gov/pubmed/34483926
http://dx.doi.org/10.3389/fphar.2021.718086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416464/
https://www.ncbi.nlm.nih.gov/pubmed/34483926
http://dx.doi.org/10.3389/fphar.2021.718086

Ejemplares similares